TeraGo’s Q4 EBITDA Collapse Signals Unseen Operational Deterioration

The market's calm reaction to TeraGo's fourth-quarter report suggests the headline decline was largely priced in. The stock held steady at 0.84 CAD after the print. Yet the details reveal a deeper operational reset than the whisper number likely anticipated. The company reported revenue of 6.2 million CAD, a 5.6% year-over-year decline. For a business in a growth phase, this drop from stability to contraction was a clear miss against the expectation of at least holding ground.

The widening net loss confirms the pressure is hitting the bottom line. TeraGo's net loss widened to 4.9 million CAD from 3.2 million CAD in the prior year. This expansion signals that cost controls or revenue support were insufficient to offset the top-line erosion. The real expectation gap, however, lies in the adjusted EBITDA. The metric fell 26.3% year-over-year to 885 thousand CAD. This sharp deterioration in core operating cash flow points to significant margin compression or operational inefficiencies that the market may have underestimated.

The whisper number for Q4 likely baked in a revenue decline and a loss expansion, given the company's stated macroeconomic pressures and strategic account cuts. But the magnitude of the adjusted EBITDA drop suggests the operational reset was more severe. The market's stable price implies the worst was already discounted, but the miss here raises the bar for the promised recovery later in 2025.

The Silver Linings: Customer Health vs. Financial Noise

While the financials told a story of contraction, TeraGo's operational metrics reveal a customer base that is not just surviving but strengthening. These are the details the market likely overlooked in the quarterly noise. The most telling sign is the 4.4% increase in Average Revenue Per Account (ARPA). This pricing power or successful upselling suggests the company is not merely losing customers but also deepening relationships with those it retains. That's a positive signal for future revenue quality, even as total revenue declined.

Customer retention improved as well, with churn falling to 0.7% from 0.8%. In a tough macroeconomic environment, this slight uptick in loyalty is a tangible win. It indicates the company's strategy of exiting unprofitable accounts is working, leaving behind a higher-quality, more stable base. The market's focus on the headline revenue drop may have obscured this underlying health.

TeraGo holds 91% of Canada's mmWave spectrum, a unique and defensible position for its 5G and fixed wireless strategy. This isn't a quarterly metric, but it's a foundational advantage that underpins the entire growth thesis. The CEO highlighted this as a key strategic advantage, and it represents a massive, non-renewable resource that competitors cannot easily replicate.

The expectation gap here is clear. The market was pricing in a decline, but it may not have fully appreciated the quality of the remaining customer base or the strategic value of the spectrum. These are the silver linings that could become the catalysts for the promised recovery later in 2025.

The Market's Verdict: Stock Price Reaction and the Expectation Gap

The market's verdict was delivered in a single, telling number: the stock price remained unchanged at 0.84 CAD after the earnings release. This stability is the clearest signal of an expectation gap. It means the negative financials were largely priced in, but the operational deterioration was not.

For all the talk of macroeconomic pressures and strategic account cuts, the whisper number for Q4 likely anticipated a revenue decline and a widening loss. The market's calm reaction suggests those were the bad news already discounted. The real surprise, and the reason the stock didn't pop or crash, was the sharp drop in adjusted EBITDA. The metric fell 26.3% year-over-year to 885 thousand CAD. This wasn't just a revenue miss; it was a signal of severe margin compression or operational inefficiency that the market may have underestimated. In other words, the bad news was expected, but the operational deterioration was a surprise.

This dynamic is classic "sell the news" for a stock already battered. The company had already been trading at a discount, and the report confirmed the worst. The market's job was done. The expectation gap now shifts to the forward view. The CEO has guided for revenue growth later in 2025, but the market is effectively saying: "We saw the decline; now show us the recovery." The stock's lack of reaction means there's no immediate catalyst. The focus will be on whether the company can deliver on that promise of a turnaround, starting with stabilizing its core operating cash flow.

The Restatement Cloud: Accounting Noise vs. Business Reality

The restatement announcement added a layer of complexity to the quarterly analysis, but it's crucial to separate the accounting noise from the core business reality. TeraGo announced in March 2026 that it was restating its previously issued unaudited interim condensed consolidated financial statements for the quarter and nine months ended September 30, 2025. The adjustment was due to an error in accounting for a non-routine sale and leaseback transaction, requiring a revision to the application of IFRS 16. While the restatement itself was non-cash, it does affect the comparability of prior periods.

This timing-just before the Q4 earnings release-created a distraction. The market was already digesting a quarter of contraction and a sharp drop in adjusted EBITDA. The restatement announcement introduced a new element of uncertainty, forcing analysts to question the reliability of the prior-year numbers used for comparison. It's a classic case of accounting noise obscuring the signal.

Yet, for assessing the underlying business trend, the restatement's impact is limited. The adjustment relates to a specific transaction in Q3 2025, not the operational performance of the fourth quarter. The core metrics for Q4-the revenue decline, the net loss expansion, and the 26.3% drop in adjusted EBITDA-stand on their own. The restatement doesn't change the fact that the company is navigating macroeconomic pressures and executing a strategic account cleanup. It simply means the financials for the third quarter of last year need to be viewed with a different lens.

The bottom line is that the restatement added a cloud to the analysis, potentially distracting investors from the more pressing question: how quickly can the company stabilize its core operating cash flow? The market's focus on the Q4 print suggests it was more concerned with the operational deterioration than with the prior-period accounting correction. For now, the restatement is a footnote to the main story of a business in transition.

Catalysts and Risks: What to Watch for the Next Expectation Gap

The market's current stability is a verdict on the past, not a promise for the future. The stock's unchanged price after the Q4 report signals that the decline was priced in. The next expectation gap will hinge on whether management can deliver on the promised recovery. Three forward-looking factors will determine if that stability is justified or if the next earnings call triggers a reset.

First, watch for concrete guidance on 2026. The CEO has stated that revenue growth is expected to resume later in 2025, but that's a vague timeline. The market needs specific targets for both revenue growth and adjusted EBITDA. This guidance will be the ultimate test of management's confidence in reversing the recent trends. Without it, the recovery remains a hope, not a plan. The whisper number for 2026 will be set by this guidance, and any shortfall would likely trigger a negative re-rating.

Second, monitor the execution of new fixed wireless broadband product launches. The company's entire growth thesis depends on expanding its Fixed Wireless Access and 5G technologies to meet market demand. The recent improvement in ARPA and churn suggests the customer base is healthy, but that must translate into new installations and sales. Any delay or underperformance in launching and scaling these products would confirm the risk of delayed revenue recognition and undermine the turnaround narrative.

The primary risk, however, is that the widening net loss and declining cash flow persist. The company ended Q4 with a cash position of 12.6 million CAD, but the trend in cash from operations is a concern. If the net loss continues to widen, it will test the company's financial flexibility from recent financing. The market is already pricing in a lack of near-term profitability, but a prolonged cash burn could force a future capital raise or strategic shift, resetting expectations downward.

In short, the expectation gap has shifted from "Will there be a decline?" to "How fast and how solid will the recovery be?" The catalysts are clear: specific 2026 guidance and successful product execution. The risk is persistent financial pressure. The stock's current calm will be short-lived if the next print fails to close this new gap.